Recent News

• 10.25.2025 - Tussentijdse gegevens van Merus over petosemtamab bij gemetastaseerde colorectale kanker tonen monotherapie-activiteit en robuust responspercentage aan in combinatie met FOLFOX/FOLFIRI, alsook goed verdragen veiligheid
• 10.24.2025 - Merus’ Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety
• 10.14.2025 - Op de AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics kondigt Merus de publicatie aan van het abstract over petosemtamab in gemetastaseerde colorectale kanker
• 10.14.2025 - Merus Announces Publication of an Abstract on Petosemtamab in Metastatic Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
• 10.13.2025 - Merus kondigt de selectie aan van het abstract: Petosemtamab in Metastatic Colorectal Cancer (petosemtamab in gemetastaseerde colorectale kanker) voor mondelinge presentatie in de plenaire sessie op de AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
• 10.13.2025 - Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
• 09.29.2025 - Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
• 09.29.2025 - Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
• 09.19.2025 - Etzer Darout, Ph.D.

Recent Filings

• 10.21.2025 - SC 14D9 Solicitation, recommendation statements
• 10.21.2025 - SC TO-T Tender offer statement by Third Party
• 10.03.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 10.03.2025 - SC14D9C Written communication relating to third party tender offer
• 09.29.2025 - SC TO-C Written communication relating to an issuer or third party
• 09.29.2025 - SC14D9C Written communication relating to third party tender offer
• 09.29.2025 - EX-99.1 EX-99.1
• 09.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 09.29.2025 - SC14D9C Written communication relating to third party tender offer
• 09.29.2025 - 8-K Current report